Triedman and Newburger Trends in Congenital Heart Disease 2717 validating these
extraordinary procedural and technical innovations has been described and communicated …

Transcatheter balloon valvuloplasty for the treatment of aortic and pulmonary valve stenosis
was first described nearly 40 years ago. Since that time, the technique has been refined in …

Objectives: The aim of this study was to evaluate practice patterns and outcomes of a
contemporary group of patients undergoing balloon aortic valvuloplasty (BAV) for congenital …

Objective To describe contemporary outcomes of balloon aortic valvuloplasty (BAVP)
performed in 22 US centers. Background: BAVP constitutes first‐line therapy for congenital …

Background: We sought to identify predictive factors for aortic valve (AoV) surgery after
neonatal balloon aortic valvuloplasty (BAV) and characterize clinical outcomes of AoV …

For neonates with critical congenital heart disease requiring intervention, transcatheter
approaches for many conditions have been established over the past decades. These …

Percutaneous therapies for congenital heart disease have evolved rapidly in the past 3
decades. This has occurred despite limited investment from industry and support from …

Congenital heart interventions are now replacing surgical palliation and correction in an
evolving number of congenital heart defects. Right ventricular outflow tract and ductus …

Given the rising costs of health care in today's economic environment, the need for effective,
value-driven care has never been more pressing. While the US health care system strives …

Balloon aortic valvuloplasty (BAV) is preferred by most centers over surgery for the treatment
of congenital valve stenosis, due to its less invasive nature and faster recovery time. A …